These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 30772212)

  • 1. Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital.
    Wang Y; Chen XF; Xie XL; Xiao M; Yang Y; Zhang G; Zhang JJ; Duan SM; Zhang Q; Zhang P; Tsui C; Xu YC
    J Microbiol Immunol Infect; 2019 Jun; 52(3):456-464. PubMed ID: 30772212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
    Yim J; Lee Y; Kim M; Seo YH; Kim WH; Yong D; Jeong SH; Lee K; Chong Y
    Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
    Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
    Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong by the tentative EUCAST disc diffusion method.
    Ho PL; Yau CY; Ho LY; Lai EL; Liu MC; Tse CW; Chow KH
    Anaerobe; 2017 Oct; 47():51-56. PubMed ID: 28414107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction.
    Wallace MJ; Jean S; Wallace MA; Burnham CD; Dantas G
    mBio; 2022 Feb; 13(1):e0360321. PubMed ID: 35038926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of carbapenem resistance in Bacteroides fragilis in China.
    Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
    Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics.
    Hansen KCM; Schwensen SAF; Henriksen DP; Justesen US; Sydenham TV
    Anaerobe; 2017 Oct; 47():79-85. PubMed ID: 28445776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS.
    Jeverica S; Sóki J; Premru MM; Nagy E; Papst L
    Anaerobe; 2019 Aug; 58():30-34. PubMed ID: 30716401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaerobic blood culture isolates in a Norwegian university hospital: identification by MALDI-TOF MS vs 16S rRNA sequencing and antimicrobial susceptibility profiles.
    Handal N; Bakken Jørgensen S; Smith Tunsjø H; Johnsen BO; Leegaard TM
    APMIS; 2015 Sep; 123(9):749-58. PubMed ID: 26123879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
    Byun JH; Kim M; Lee Y; Lee K; Chong Y
    Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antimicrobial resistance and the cfiA resistance gene in Danish Bacteroides fragilis group isolates since 1973.
    Ferløv-Schwensen SA; Sydenham TV; Hansen KCM; Hoegh SV; Justesen US
    Int J Antimicrob Agents; 2017 Oct; 50(4):552-556. PubMed ID: 28666749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
    Liu CY; Huang YT; Liao CH; Yen LC; Lin HY; Hsueh PR
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3161-8. PubMed ID: 18625771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimicrobial Susceptibility of Pathogenic Gram-positive Anaerobic Cocci: Data of a University Hospital in Turkey].
    Akgül Ö; Söyletir G; Ülger Toprak N
    Mikrobiyol Bul; 2020 Jul; 54(3):404-417. PubMed ID: 32755517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry.
    Nagy E; Maier T; Urban E; Terhes G; Kostrzewa M;
    Clin Microbiol Infect; 2009 Aug; 15(8):796-802. PubMed ID: 19438622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).
    Snydman DR; Jacobus NV; McDermott LA; Golan Y; Hecht DW; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rihs JD; Yu VL; Venezia R; Finegold SM; Rosenblatt JE; Gorbach SL
    Clin Infect Dis; 2010 Jan; 50 Suppl 1():S26-33. PubMed ID: 20067390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong, 2020-2021.
    Fang H; Li X; Yan MK; Tong MK; Chow KH; Cheng VC; Ho PL
    Anaerobe; 2023 Aug; 82():102756. PubMed ID: 37429411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Klebsiella isolates by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and determination of antimicrobial resistance with VITEK 2 advanced expert system (AES).
    Karagöz A; Acar S; Körkoca H
    Turk J Med Sci; 2015; 45(6):1335-44. PubMed ID: 26775392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of MALDI-TOF MS and VITEK 2 system for laboratory diagnosis of Granulicatella and Abiotrophia species causing invasive infections.
    Ratcliffe P; Fang H; Thidholm E; Boräng S; Westling K; Özenci V
    Diagn Microbiol Infect Dis; 2013 Nov; 77(3):216-9. PubMed ID: 24034902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic patterns of antimicrobial susceptibilities for Bacteroides spp. worldwide: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2007-2020.
    Wu PH; Chen CH; Lin HH; Tseng KH; Ko WC; Ho MW; Hsueh PR
    Int J Antimicrob Agents; 2023 Jul; 62(1):106822. PubMed ID: 37088437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.